{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35714107", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "17"}], "Language": ["eng"], "ELocationID": ["e0010484", "10.1371/journal.pntd.0010484"], "Journal": {"ISSN": "1935-2735", "JournalIssue": {"Volume": "16", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "PLoS neglected tropical diseases", "ISOAbbreviation": "PLoS Negl Trop Dis"}, "ArticleTitle": "Withania somnifera (L.) Dunal whole-plant extracts exhibited anti-sporotrichotic effects by destabilizing peripheral integrity of Sporothrix globosa yeast cells.", "Pagination": {"StartPage": "e0010484", "MedlinePgn": "e0010484"}, "Abstract": {"AbstractText": ["Chronic topical cases of Sporotrichosis, a chronic fungal infection caused by the ubiquitously present cryptic members of the Sporothrix species complex, are treated with oral administrations of itraconazole. However, severe pulmonary or disseminated cases require repeated intra-venous doses of amphotericin B or even surgical debridement of the infected tissue. The unavoidable adverse side-effects of the current treatments, besides the growing drug resistance among Sporothrix genus, demands exploration of alternative therapeutic options. Medicinal herbs, due to their multi-targeting capacity, are gaining popularity amidst the rising antimicrobial recalcitrance. Withania somnifera is a well-known medicinal herb with reported antifungal activities against several pathogenic fungal genera. In this study, the antifungal effect of the whole plant extract of W. somnifera (WSWE) has been explored for the first time, against an itraconazole resistant strain of S. globosa. WSWE treatment inhibited S. globosa yeast form growth in a dose-dependent manner, with IC50 of 1.40 mg/ml. Minimum fungicidal concentration (MFC) was found to be 50 mg/ml. Sorbitol protection and ergosterol binding assays, revealed that anti-sporotrichotic effects of WSWE correlated well with the destabilization of the fungal cell wall and cell membrane. This observation was validated through dose-dependent decrease in overall ergosterol contents in WSWE-treated S. globosa cells. Compositional analysis of WSWE through high performance liquid chromatography (HPLC) exhibited the presence of several anti-microbial phytochemicals like withanone, withaferin A, withanolides A and B, and withanoside IV and V. Withanone and withaferin A, purified from WSWE, were 10-20 folds more potent against S. globosa than WSWE, thus, suggesting to be the major phytocompounds responsible for the observed anti-sporotrichotic activity. In conclusion, this study has demonstrated the anti-sporotrichotic property of the whole plant extract of W. somnifera against S. globosa that could be further explored for the development of a natural antifungal agent against chronic Sporotrichosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Haridwar, India."}, {"Identifier": [], "Affiliation": "Patanjali Yog Peeth (UK) Trust, Glasgow, United Kingdom."}], "LastName": "Balkrishna", "ForeName": "Acharya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}], "LastName": "Verma", "ForeName": "Sudeep", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}], "LastName": "Mulay", "ForeName": "Vallabh Prakash", "Initials": "VP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}], "LastName": "Gupta", "ForeName": "Ashish Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}], "LastName": "Haldar", "ForeName": "Swati", "Initials": "S"}, {"Identifier": ["0000-0001-8509-0882"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Haridwar, India."}, {"Identifier": [], "Affiliation": "Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India."}], "LastName": "Varshney", "ForeName": "Anurag", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS Negl Trop Dis", "NlmUniqueID": "101291488", "ISSNLinking": "1935-2727"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antifungal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "304NUG5GF4", "NameOfSubstance": "Itraconazole"}], "SupplMeshList": ["Sporothrix globosa"], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antifungal Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Itraconazole"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Saccharomyces cerevisiae"}, {"QualifierName": [], "DescriptorName": "Sporothrix"}, {"QualifierName": ["microbiology"], "DescriptorName": "Sporotrichosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Withania"}], "CoiStatement": "I have read the journal\u2019s policy and the authors of this manuscript have the following competing interests: Acharya Balkrishna is a trustee in Divya Yog Mandir Trust, Haridwar, India that governs Divya Pharmacy, Haridwar. In addition, Acharya Balkrishna is one of the founding promoter and holds an honorary managerial position in Patanjali Ayurved Ltd, Haridwar, India. Divya Pharmacy and Patanjali Ayurveda Ltd commercially manufacture and sell several ayurvedic products, some of which include Withania somnifera as herbal component. Divya Pharmacy and/or Patanjali Ayurved Ltd, Haridwar, India were not involved in any aspect of this study. In addition, Anurag Varshney is an adjunct professor in Department of Allied and Applied Sciences, University of Patanjali, NH-58, Haridwar-249405, Uttarakhand, India; and in Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi-110067, India."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sporotrichosis. In: Centers for Disease Control and Prevention [Internet].\n2020.  [cited 3 Jan 2022] pp. 1\u20134. Available: https://www.cdc.gov/fungal/diseases/sporotrichosis/index.html"}, {"Citation": "Romeo O, Criseo G. What lies beyond genetic diversity in sporothrix schenckii species complex?: New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates. Virulence. 2013;4: 203\u2013206. doi: 10.4161/viru.23467", "ArticleIdList": ["10.4161/viru.23467", "PMC3711977", "23334066"]}, {"Citation": "Concei\u00e7\u00e3o-Silva F, Morgado FN. Immunopathogenesis of human sporotrichosis: What we already know. J Fungi. 2018;4: 22\u201332. doi: 10.3390/jof4030089", "ArticleIdList": ["10.3390/jof4030089", "PMC6162489", "30065160"]}, {"Citation": "de Lima Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and sporotrichosis. Clin Microbiol Rev. 2011;24: 354\u2013633. doi: 10.1128/CMR.00007-11", "ArticleIdList": ["10.1128/CMR.00007-11", "PMC3194828", "21976602"]}, {"Citation": "Lopes-Bezerra LM, Mora-Montes HM, Zhang Y, Nino-Vega G, Rodrigues AM, De Camargo ZP, et al.. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Med Mycol. 2018;56: S126\u2013S143. doi: 10.1093/mmy/myx103", "ArticleIdList": ["10.1093/mmy/myx103", "29538731"]}, {"Citation": "Ram\u00edrez-Soto MC, Aguilar-AWncori EG, Tirado-S\u00e1nchez A, Bonifaz A. Ecological determinants of sporotrichosis etiological agents. J Fungi. 2018;4: 1\u201311. doi: 10.3390/jof4030095", "ArticleIdList": ["10.3390/jof4030095", "PMC6162718", "30103554"]}, {"Citation": "Rossato L, Moreno F, Jamalian A, Stielow B, Almeida R De. crossm Sporothrix brasiliensis Elucidated by Ultra-High-Resolution. 2018; 1\u201310.", "ArticleIdList": ["PMC6001607", "29898987"]}, {"Citation": "Criseo G, Zungri D, Romeo O. Stable yeast-like form of Sporothrix schenckii: Lack of dimorphic stage. J Clin Microbiol. 2008;46: 3870\u20133871. doi: 10.1128/JCM.01135-08", "ArticleIdList": ["10.1128/JCM.01135-08", "PMC2576565", "18799707"]}, {"Citation": "Camacho E, Le\u00f3n-Navarro I, Rodr\u00edguez-Brito S, Mendoza M, Ni\u00f1o-Vega GA. Molecular epidemiology of human sporotrichosis in Venezuela reveals high frequency of Sporothrix globosa. BMC Infect Dis. 2015;15: 1\u201310. doi: 10.1186/s12879-015-0839-6", "ArticleIdList": ["10.1186/s12879-015-0839-6", "PMC4348157", "25880588"]}, {"Citation": "Queiroz-Telles F, Buccheri R, Benard G. Sporotrichosis in immunocompromised hosts. J Fungi. 2019;5: 1\u201323. doi: 10.3390/jof5010008", "ArticleIdList": ["10.3390/jof5010008", "PMC6463096", "30641918"]}, {"Citation": "Mahajan VK. Sporotrichosis: An overview and therapeutic options. Dermatol Res Pract. 2014;2014: 1\u201313. doi: 10.1155/2014/272376", "ArticleIdList": ["10.1155/2014/272376", "PMC4295339", "25614735"]}, {"Citation": "Alves MDM, Milan EP, da Silva-Rocha WP, da Costa AS de S, Maciel BA, Vale PHC, et al.. Fatal pulmonary sporotrichosis caused by sporothrix brasiliensis in Northeast Brazil. PLoS Negl Trop Dis. 2020;14: 1\u201311. doi: 10.1371/journal.pntd.0008141", "ArticleIdList": ["10.1371/journal.pntd.0008141", "PMC7274469", "32453723"]}, {"Citation": "Waller SB, Dalla Lana DF, Quatrin PM, Ferreira MRA, Fuentefria AM, Mezzari A. Antifungal resistance on Sporothrix species: an overview. Brazilian J Microbiol. 2021;52: 73\u201380. doi: 10.1007/s42770-020-00307-z", "ArticleIdList": ["10.1007/s42770-020-00307-z", "PMC7966672", "32476087"]}, {"Citation": "Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2014;53: 3\u201314. doi: 10.1093/mmy/myu062", "ArticleIdList": ["10.1093/mmy/myu062", "25526781"]}, {"Citation": "Rodrigues AM, de Hoog GS, de C\u00e1ssia Pires D, Brihante RSN, da Costa Sidrim JJ, Gadelha MF, et al.. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis. 2014;14: 1\u20139. doi: 10.1186/1471-2334-14-219", "ArticleIdList": ["10.1186/1471-2334-14-219", "PMC4021050", "24755107"]}, {"Citation": "Waller SB, Madrid IM, Faria RO De, Cleff MB, Roberto J, Mello B De, et al.. Anti- Sporothrix spp. activity of medicinal plants. Brazilian J Pharm Sci. 2016;52: 221\u2013238. doi: 10.1590/S1984-82502016000200001", "ArticleIdList": ["10.1590/S1984-82502016000200001"]}, {"Citation": "Garcia Ferreira P, Pereira Borba-Santos L, Noronha LL, Deckman Nicoletti C, de S\u00e1 Haddad Queiroz M, de Carvalho da Silva F, et al.. Synthesis, Stability Studies, and Antifungal Evaluation of Substituted \u03b1- and \u03b2-2,3-Dihydrofuranaphthoquinones against Sporothrix brasiliensis and Sporothrix schenckii. Molecules. 2019;24. doi: 10.3390/molecules24050930", "ArticleIdList": ["10.3390/molecules24050930", "PMC6429059", "30866442"]}, {"Citation": "Masoko P, Picard J, Eloff JN. Antifungal activities of six South African Terminalia species (Combretaceae). J Ethnopharmacol. 2005;99: 301\u2013308. doi: 10.1016/j.jep.2005.01.061", "ArticleIdList": ["10.1016/j.jep.2005.01.061", "15894142"]}, {"Citation": "Masoko P, Mdee LK, Mampuru LJ, Eloff JN. Biological activity of two related triterpenes isolated from Combretum nelsonii (Combretaceae) leaves. Nat Prod Res. 2008;22: 1074\u20131084. doi: 10.1080/14786410802267494", "ArticleIdList": ["10.1080/14786410802267494", "18780249"]}, {"Citation": "Masoko P, Picard J, Howard RL, Mampuru LJ, Eloff JN. In vivo antifungal effect of Combretum and Terminalia species extracts on cutaneous wound healing in immunosuppressed rats. Pharm Biol. 2010;48: 621\u2013632. doi: 10.3109/13880200903229080", "ArticleIdList": ["10.3109/13880200903229080", "20645734"]}, {"Citation": "Seepe HA, Ramakadi TG, Lebepe CM, Amoo SO, Nxumalo W. Antifungal Activity of Isolated Compounds from the Leaves of Combretum erythrophyllum (Burch.) Sond. and Withania somnifera (L.) Dunal against Fusarium Pathogens. Molecules. 2021;26: 1\u201321. doi: 10.3390/molecules26164732", "ArticleIdList": ["10.3390/molecules26164732", "PMC8401019", "34443320"]}, {"Citation": "Khanchandani N, Shah P, Kalwani T, Ardeshna A, Dharajiya D. Antibacterial and Antifungal Activity of Ashwagandha (Withania somnifera L.): A review. J Drug Deliv Ther. 2019;9: 154\u2013161. doi: 10.22270/jddt.v9i5-s.3573", "ArticleIdList": ["10.22270/jddt.v9i5-s.3573"]}, {"Citation": "Javaid A, Akhtar R. Antifungal activity of methanolic root extract of Withania sommnifera against Fusarium oxysporum f. sp. cepae. African J Tradit Complement Altern Med. 2015;12: 22\u201327. doi: 10.4314/ajtcam.v12i5.4", "ArticleIdList": ["10.4314/ajtcam.v12i5.4"]}, {"Citation": "Nefzi A, Ben Abdallah RA. Antifungal activity of aqueous and organic extracts from Withania somnifera L. against Fusarium oxysporum f. sp. radicis-lycopersici. J Microb Biochem Technol. 2016;8: 144\u2013150. doi: 10.4172/1948-5948.1000277", "ArticleIdList": ["10.4172/1948-5948.1000277"]}, {"Citation": "Vyas VK, Bhandari P, Patidar R. A Comprehensive Review on Withania somnifera Dunal. J Nat Remedies. 2011;11: 1\u201313."}, {"Citation": "Mani-L\u00f3pez E, Cort\u00e9s-Zavaleta O, L\u00f3pez-Malo A. A review of the methods used to determine the target site or the mechanism of action of essential oils and their components against fungi. SN Appl Sci. 2021;3: 1\u201325. doi: 10.1007/s42452-020-04102-1", "ArticleIdList": ["10.1007/s42452-020-04102-1"]}, {"Citation": "Olajuyigbe OO, Afolayan AJ. Pharmacological assessment of the medicinal potential of Acacia mearnsii de wild: Antimicrobial and toxicity activities. Int J Mol Sci. 2012;13: 4255\u20134267. doi: 10.3390/ijms13044255", "ArticleIdList": ["10.3390/ijms13044255", "PMC3344212", "22605976"]}, {"Citation": "Kanafani ZA, Perfect JR. Resistance to antifungal agents: Mechanisms and clinical impact. Clin Infect Dis. 2008;46: 120\u2013128. doi: 10.1086/524071", "ArticleIdList": ["10.1086/524071", "18171227"]}, {"Citation": "Leite MCA, De Brito Bezerra AP, De Sousa JP, Guerra FQS, De Oliveira Lima E. Evaluation of antifungal activity and mechanism of action of citral against Candida albicans. Evidence-based Complement Altern Med. 2014;2014: 1\u20139. doi: 10.1155/2014/378280", "ArticleIdList": ["10.1155/2014/378280", "PMC4163309", "25250053"]}, {"Citation": "Liesche J, Marek M, G\u00fcnther-Pomorski T. Cell wall staining with Trypan blue enables quantitative analysis of morphological changes in yeast cells. Front Microbiol. 2015;6: 1\u20138. doi: 10.3389/fmicb.2015.00107", "ArticleIdList": ["10.3389/fmicb.2015.00107", "PMC4324143", "25717323"]}, {"Citation": "Scott JH, Schekman R. Lyticase: Endoglucanase and protease activities that act together in yeast cell lysis. J Bacteriol. 1980;142: 414\u2013423. doi: 10.1128/jb.142.2.414-423.1980", "ArticleIdList": ["10.1128/jb.142.2.414-423.1980", "PMC293993", "6991473"]}, {"Citation": "Rogers TR. Antifungal drug resistance: Does it matter? Int J Infect Dis. 2002;6: S47\u2013S53. doi: 10.1016/s1201-9712(02)90154-2", "ArticleIdList": ["10.1016/s1201-9712(02)90154-2", "12044289"]}, {"Citation": "Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18: 319\u2013331. doi: 10.1038/s41579-019-0322-2", "ArticleIdList": ["10.1038/s41579-019-0322-2", "PMC7231573", "32047294"]}, {"Citation": "Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, De Camargo ZP, et al.. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol. 2015;53: 178\u2013188. doi: 10.1093/mmy/myu056", "ArticleIdList": ["10.1093/mmy/myu056", "25394542"]}, {"Citation": "Almeida-Paes R, Oliveira MME, Freitas DFS, Do Valle ACF, Gutierrez-Galhardo MC, Zancop\u00e9-Oliveira RM. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Med Mycol. 2017;55: 507\u2013517. doi: 10.1093/mmy/myw103", "ArticleIdList": ["10.1093/mmy/myw103", "27771622"]}, {"Citation": "Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med. 2015;5: 1\u201322. doi: 10.1101/cshperspect.a019752", "ArticleIdList": ["10.1101/cshperspect.a019752", "PMC4484955", "25384768"]}, {"Citation": "Chen F, Jiang R, Dong S, Yan B. Efficient treatment of sporothrix globosa infection using the antibody elicited by recombinant phage nanofibers. Front Pharmacol. 2019;10: 1\u20138. doi: 10.3389/fphar.2019.00160", "ArticleIdList": ["10.3389/fphar.2019.00160", "PMC6400886", "30873031"]}, {"Citation": "Martin KW, Ernst E. Herbal medicines for treatment of fungal infections: A systematic review of controlled clinical trials. Mycoses. 2004;47: 87\u201392. doi: 10.1046/j.1439-0507.2003.00951.x", "ArticleIdList": ["10.1046/j.1439-0507.2003.00951.x", "15078424"]}, {"Citation": "Gowhar O, Singh NN, Sultan S, Ain TS, Mewara A, Shah I. Natural Herbs as Alternative to Synthetic Antifungal Drugs- The Future Challenging Therapy. Br Biomed Bull. 2015;3: 440\u2013542."}, {"Citation": "Talevi A. Multi-target pharmacology: Possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective. Front Pharmacol. 2015;6: 1\u20137. doi: 10.3389/fphar.2015.00205", "ArticleIdList": ["10.3389/fphar.2015.00205", "PMC4585027", "26441661"]}, {"Citation": "Makhoba XH, Viegas C, Mosa RA, Viegas FPD, Pooe OJ. Potential impact of the multi-target drug approach in the treatment of some complex diseases. Drug Des Devel Ther. 2020;14: 3235\u20133249. doi: 10.2147/DDDT.S257494", "ArticleIdList": ["10.2147/DDDT.S257494", "PMC7440888", "32884235"]}, {"Citation": "El-hefny M, Salem MZM, Behiry SI. The Potential Antibacterial and Antifungal Activities of Wood Treated with Withania somnifera Fruit Extract, and the Phenolic, Caffeine, and Flavonoid Composition of the Extract According to HPLC. Processes. 2019;8: 1\u201313."}, {"Citation": "Aboody MS Al, Mickymaray S. Anti-fungal efficacy and mechanisms of flavonoids. Antibiotics. 2020;9: 1\u201343. doi: 10.3390/antibiotics9020045", "ArticleIdList": ["10.3390/antibiotics9020045", "PMC7168129", "31991883"]}, {"Citation": "Gaur SK, Kumar K. A steroidal lactone, withaferin A acts as a potential insect growth regulator against polyphagous pest, Spodoptera litura (Lepidoptera: Noctuidae). Arch Phytopathol Plant Prot. 2021;54: 625\u2013646. doi: 10.1080/03235408.2020.1853312", "ArticleIdList": ["10.1080/03235408.2020.1853312"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "6"}, {"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "6", "Day": "17", "Hour": "13", "Minute": "34"}, {"Year": "2022", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["35714107", "PMC9205525", "10.1371/journal.pntd.0010484", "PNTD-D-22-00025"]}}], "PubmedBookArticle": []}